Department of Anesthesiology and Critical Care Medicine, Hokkaido University Hospital, Kita-15, Nishi-7, Kita-Ku, Sapporo, 060-8638, Japan.
J Anesth. 2023 Aug;37(4):641-644. doi: 10.1007/s00540-023-03209-0. Epub 2023 Jun 6.
The local anesthetic (LA) systemic toxicity of trunk blocks is a major concern. Recently, modified thoracoabdominal nerve block through perichondrial approach (M-TAPA) has attracted attention; however, plasma LA level is unknown. We tested whether the peak plasma LA concentration following M-TAPA, using 25 mL of 0.25% levobupivacaine mixed with epinephrine on each side, would be below the toxic level (2.6 μg/mL). We recruited 10 patients undergoing abdominal surgery with planned M-TAPA between November 2021 and February 2022. In all patients, 25 mL of 0.25% levobupivacaine mixed with 1:200,000 epinephrine was administered on each side. Blood samples were obtained at 10, 20, 30, 45, 60, and 120 min after the block. The highest individual peak and the mean peak plasma LA concentrations were 1.03 and 0.73 μg/mL, respectively. We could not capture the peak in five patients; however, the highest concentrations in all patients were significantly lower than the toxic level. A negative correlation between the peak level and body weight was observed. Our results indicated that the plasma LA concentration following M-TAPA using total of 50 mL of 0.25% levobupivacaine with epinephrine remains below the toxic level. Further research is required due to the small sample size of this study.Trial registry number: UMIN000045406.
躯干部位神经阻滞的局部麻醉药(LA)全身毒性是一个主要关注点。最近,改良经软骨膜胸廓腹壁神经阻滞(M-TAPA)引起了关注;然而,其血浆 LA 水平尚不清楚。我们检测了使用每侧 25mL 0.25%左旋布比卡因混合肾上腺素(每侧各 25mL)行 M-TAPA 后,血浆 LA 浓度峰值是否低于中毒水平(2.6μg/mL)。我们招募了 2021 年 11 月至 2022 年 2 月期间计划行 M-TAPA 的 10 例腹部手术患者。所有患者均在两侧给予 0.25%左旋布比卡因混合 1:200,000 肾上腺素各 25mL。在阻滞后 10、20、30、45、60 和 120min 采血。个体最高峰值和平均最高血浆 LA 浓度分别为 1.03 和 0.73μg/mL。我们无法在 5 例患者中捕捉到峰值;然而,所有患者的最高浓度明显低于中毒水平。观察到峰值与体重之间呈负相关。我们的结果表明,使用总共 50mL 0.25%左旋布比卡因加肾上腺素行 M-TAPA 后,血浆 LA 浓度仍低于中毒水平。由于本研究的样本量较小,需要进一步研究。试验注册号:UMIN000045406。